NCT04039945 Fr1da Early Diagnosis and Care of Type 1 Diabetes
| NCT ID | NCT04039945 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helmholtz Zentrum München |
| Condition | Type 1 Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 285,000 participants |
| Start Date | 2015-02 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 285,000 participants in total. It began in 2015-02 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Fr1da study: "Early diagnosis and care of type 1 diabetes" aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.
Eligibility Criteria
written informed consent by one custodial parent
Contact & Investigator
Anette-Gabriele Ziegler, Prof.Dr.med.
✉ diabetes.frueherkennung@helmholtz-muenchen.de📞 +49 800-4648835
Frequently Asked Questions
Who can join the NCT04039945 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 10 Years, studying Type 1 Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04039945 currently recruiting?
Yes, NCT04039945 is actively recruiting participants. Contact the research team at diabetes.frueherkennung@helmholtz-muenchen.de for enrollment information.
Where is the NCT04039945 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT04039945 clinical trial?
NCT04039945 is sponsored by Helmholtz Zentrum München. The trial plans to enroll 285,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.